FSD Pharma Begins Phase 1 In-human Safety and Tolerability Study of Ultra Micro-Palmitolylethanolamide (PEA) Cannabis Investing News
Algernon Scales up Manufacturing of NP-120 (Ifenprodil) to Prepare for Coronavirus and Acute Lung Injury US Clinical Trials Biotech Investing
Algernon Explores the Use of NP-120 (Ifenprodil) as a Novel Treatment for Coronavirus Biotech Investing
Cardiol Therapeutics Receives Health Canada Approval for Phase 1 Study of its Pharmaceutically Produced Cannabidiol (CBD) Formulation Cannabis Investing News
